Related Experiment Video
Updated: Jun 1, 2025

Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
Physiological Data Collected From Wearable Devices Identify and Predict Inflammatory Bowel Disease Flares
Robert P Hirten1, Matteo Danieletto2, Milagros Sanchez-Mayor3
1The Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York; The Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, New York; Windreich Department of Artificial Intelligence and Human Health, Icahn School of Medicine at Mount Sinai, New York, New York.
Wearable devices can track physiological changes linked to inflammatory bowel disease (IBD) activity. These metrics, including heart rate and HRV, can predict IBD flares up to seven weeks in advance.
Area of Science:
- Biomedical Engineering
- Digital Health
- Gastroenterology
Background:
- Wearable devices noninvasively monitor physiological signals.
- Several physiological parameters correlate with inflammatory bowel disease (IBD) activity.
Purpose of the Study:
- Evaluate the association between physiological metrics and IBD flares.
- Determine how these metrics change preceding an IBD flare.
Main Methods:
- Participants used wearable devices (Apple Watch, Fitbit, Oura Ring) to collect HR, RHR, HRV, steps, and oxygenation.
- Disease activity surveys and standard of care biomarkers were also collected.
- Statistical models analyzed physiological data for associations and predictive capabilities.
Main Results:
- Circadian HRV patterns differed between flare and remission states.
- Elevated HR and RHR, and reduced steps were observed during flares.
- Physiological metrics altered up to 7 weeks before symptomatic and inflammatory IBD flares.
Conclusions:
- Longitudinal data from wearables can identify IBD flares.
- Wearable device metrics show potential for monitoring and predicting IBD activity.
More Related Videos
07:38Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
Published on: September 13, 2016
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF